• About Us
  • Portfolio
  • Team
  • News & Insights
  • Contact
  • About Us
    • Who we are
    • What we do
    • Our sector focus
    • FAQs
  • Portfolio
  • Team
  • News & Insights
  • Contact
Back to portfolio
Visit
Neurent Medical
Health and Life Sciences
Ireland
Current
Headquartered in Galway, Ireland, Neurent Medical develops innovative non-surgical treatments for chronic inflammatory sino-nasal diseases. By targeting and safely disrupting the hyperactive autonomic nerves that drive underlying inflammation, their revolutionary treatment provides effective relief to patients. Neurent has its US office in Boston, MA.

Neurent’s proprietary NEUROMARK® technology enables physicians to precisely target and safely disrupt multiple underlying nerve branches to alleviate Chronic Rhinitis (CR) symptoms.
Announcements
All News
Investment Announcement

Claret Capital Partners backs Neurent Medical to further product development and accelerate US expansion

View Claret Capital Partners backs Neurent Medical to further product development and accelerate US expansion

Related Companies

See all
France
Current
View Abivax
Ireland
Current
View Deciphex
UK
Exited
View Endomag
Sweden
Current
View Mindler
Germany
Exited
View Avi Medical
United Kingdom
Current
View Cambridge Cognition
USA
Current
View Cardiac Dimensions
United Kingdom
Exited
View Healios
Funding Innovation
Across Europe.
Get in touch

Receive the latest updates from us directly into your inbox

We’re Growing. Join us on our journey.

Careers

Join the conversation and follow us on Linkedin

LinkedIn

Claret Capital Partners Limited is authorised and regulated by the Financial Conduct Authority. The content of this website is intended for professional clients and eligible counterparties only, and is not directed at or suitable for retail clients.

Claret Capital Partners Limited (company registered number 12516001) is authorised and regulated by the Financial Conduct Authority (FRN 993228).

  • Privacy Statement
  • SFDR Statement
  • Sustainability Statement
  • Public Disclosures
  • Cookie Settings
Website by Alchemy